Two Indian companies have received the green light to start human trials of their candidate COVID-19 vaccines

Published on July 7, 2020

The apparent speed at which an Indian government agency aims to test and approve a homegrown COVID-19 vaccine has created an uproar among scientists both in India, which is increasingly overwhelmed by the new coronavirus, and abroad. Science

Other news

Factors influencing diagnosis and treatment initiation for multidrugresistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review

July 6, 2020
The review identified barriers and facilitators influencing diagnosis and treatment for drugresistant tuberculosis (DR-TB) in sub- Saharan Africa. Laboratory operational challenges as well as inadequate healthcare worker knowledge, attitude and skills were the predominant barriers noted at the health system level. Predominant patient-level barriers included loss to follow-up and death, as well as

EARLY RELEASE: Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities - United States, April-May 2020

July 7, 2020
This report describes COVID-19 outbreaks in meat and poultry processing facilities reported among 23 states with 87% occurring among racial or ethnic minorities.